Analyst Actions -- 10/10/2011

 | Oct 10, 2011 | 7:51 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

s

,

siri

,

pot

,

acn

,

cy

,

txn

,

pep

,

mhs

 

Accenture downgraded at Baird

ACN was downgraded from Outperform to Neutral, Robert Baird said. Valuation call, based on a $62 price target.

-----

Cypress Semiconductor numbers cut at Sterne Agee

CY estimates were reduced through 2013, Sterne Agee said. Company will likely see lower Touchpad and Playbook sales. SRAM demand is also falling. Buy rating and new $21 price target.

-----

Diamond Foods upgraded at Jefferies

DMND was upgraded from Hold to Buy, Jefferies said. Valuation call, based on a $94 price target.

-----

Dollar Tree numbers raised at Goldman

Shares of DLTR now seen reaching $75, according to Goldman Sachs. Estimates also increased, as the company is buying back more stock. Neutral rating.

-----

Emerson downgraded at BofA/Merrill

EMR was downgraded from Buy to Neutral, Merrill Lynch said. $54 price target. Estimates also lowered, as the company is leveraged to slower economic growth—especially in Europe.

-----

Hasbro estimates, target cut at Needham

Shares of HAS now seen reaching $42, according to Needham. Estimates also reduced, as industry sales appear to be slowing.

-----

Humana estimates increased at Jefferies

HUM estimates were raised through 2012, Jefferies said. Company should benefit from a low-cost operating environment. Buy rating and $89 price target.

-----

Mead Johnson numbers raised at Credit Suisse

Shares of MJN now seen reaching $82, according to Credit Suisse. Estimates also increased, given improving operating leverage. Outperform rating.

-----

Medco Health numbers lowered at BMO

Shares of MHS now seen reaching $55, according to BMO Capital. Estimates also cut, given reduced pill volumes. Market Perform rating.

-----

Micron upgraded at Citi

MU was upgraded to Buy, Citigroup sad. $7 price target. Stock is attractive, following a 16% pullback.

-----

MSC Industrial downgraded at BofA/Merrill

MSM was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Estimates also cut, as the company could struggle to expand its margins. $74 price target.

-----

Nasdaq estimates upped at UBS

NDAQ estimates were boosted through 2012, UBS said. Trading volume continues to grow year-over-year. Buy rating and $28 price target.

-----

Pepsico estimates, target lowered at UBS

PEP estimates were cut through 2012, UBS said. Company is seeing decelerating sales growth. Buy rating and new $72 price target.

-----

Potash upgraded at Ticonderoga

POT was upgraded from Neutral to Buy, Ticonderoga Securities said. Valuation call, based on a $62 price target.

-----

Sirius XM numbers reduced at Morgan Stanley

Shares of SIRI now seen reaching $2, according to Morgan Stanley. Estimates also cut, given lower expected revenue per user. Overweight rating.

-----

Southwest Airlines downgraded at Deutsche

LUV was downgraded from Buy to Hold, Deutsche Bank said. $9 price target. AAI acquisition will boost costs.

-----

Sprint Nextel downgraded at Collins Stewart

S was downgraded to Neutral, Collins Stewart said. $3 price target. Company is spending more on CapEx.

-----

Sprint Nextel downgraded at Deutsche

S was downgraded from Buy to Hold, Deutsche Bank said. $3 price target. Company could lose 4G market share to Verizon and AT&T.

-----

Sprint Nextel downgraded at JP Morgan

Rating on S was cut from Overweight to Neutral, JP Morgan said. Network build and iPhone spending will cut into earnings.

-----

Sprint Nextel downgraded at Kaufman

Rating on S was lowered to Hold, Kaufman Bros. said. $2.50 price target. Company is leveraging up its balance sheet to pay for LTE expansion.

-----

St. Jude Medical upgraded at Morgan Stanley

STJ was upgraded from Underweight to Equal-weight, Morgan Stanley said. Stock is already pricing in lower CRM market growth.

-----

SuccessFactors downgraded at BMO

SFSF was downgraded from Outperform to Market Perform, BMO Capital said. $26 price target. Checks show that industry demand is beginning to slow.

-----

Texas Instruments numbers boosted at UBS

TXN estimates were upped through 2013, UBS said. NSM purchase should add to earnings. Outperform rating and $40 price target.

-----

Treehouse Foods downgraded at BofA/Merrill

THS was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, as the stock is up 20% year-to-date. $64 price target.

Columnist Conversations

So far, this one has held the pullback to the key low. You can have a stop either below the pullback low at 3...
The price action in Netflix (NFLX) over most of this year has formed a large ascending triangle on the weekly ...
With shares off 57 cents to $200.14, the investor sells 100,000 Dec 155 puts on the ETF at 30 cents and bought...
XOM is beginning to look quite vulnerable to a downside break. The stock spent the entire month of Augus...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.